✦ LIBER ✦

A placebo-controlled, dose-response study of dexfenfluramine in the treatment of obese patients

✍ Scribed by Thomas C. Marbury; John E. Angelo; R. Michael Gulley; Arthur Krosnick; Danny H. Sugimoto; Stephen R. Zellner

Book ID: 117090973
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 811 KB
Volume: 57
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(96)80071-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dihydroergocristine in the treatment of

Dihydroergocristine in the treatment of elderly patients with cognitive deterioration: A double-blind, placebo-controlled, dose-response study

✍ Attilio Franciosi; Guido Zavattini 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 572 KB

Amlodipine: A once-daily calcium antagon

Amlodipine: A once-daily calcium antagonist in the treatment of angina pectoris—A parallel dose-response, placebo-controlled study

✍ Udho Thadani 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 74 KB

A Double-blind, Placebo-Controlled, Repe

A Double-blind, Placebo-Controlled, Repeated Dose, Dose-Response Evaluation of Controlled-Release (CR) Oxycodone in Patients with Osteoarthritis

✍ Lacouture, P.; Roth, S.; Burch, F.; Fleischmann, R.; Iwan, T.; Kaiko, R. 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

A Comparison of Sibutramine and Dexfenfl

A Comparison of Sibutramine and Dexfenfluramine in the Treatment of Obesity

✍ Hanotin, Corinne ;Thomas, Florence ;Jones, Stephen P. ;Leutenegger, Eric ;Drouin 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 588 KB

Acute dose-response, double-blind, place

Acute dose-response, double-blind, placebo-controlled pilot study of lercanidipine in patients with angina pectoris

✍ Domenico Acanfora; Mihai Gheorghiade; Domenico Rotiroti; Luigi Trojano; Giuseppe 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 697 KB

Cianopramine and amitriptyline in the tr

Cianopramine and amitriptyline in the treatment of depressed patients — a placebo-controlled study

✍ L. Hormazabal; L. M. O. Omer; S. Ismail 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 330 KB

3-Cyano-imipramine (cianopramine) is a potent and selective inhibitor of serotonin uptake into synaptosomes. In a double-blind trial, 60 patients with various types of depression fulfilling the DSM-III criteria of depressive episodes were treated with either cianopramine (n=20, mean daily dose 3.3\_